Skip to main navigation Skip to search Skip to main content

Hypertension and fatty liver: guilty by association?

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Essential hypertension is associated with the metabolic syndrome, insulin resistance and the development of fatty liver. Fatty liver disease is a spectrum of liver diseases ranging from simple hepatic steatosis through steato-hepatitis to cirrhosis and hepatoma. The purpose of this review is to discuss the evidence for an association between essential hypertension and non-alcoholic fatty liver disease, and to consider the diagnosis and management of non-alcoholic fatty liver disease. We conclude that it is important to consider the diagnosis of fatty liver disease in hypertensive patients, to measure the liver function tests at diagnosis and not to ignore minor elevations of serum aminotransferases. Hypertensive patients with raised liver enzymes should be referred for further assessment, particularly if risk factors for progressive liver disease, such as obesity and diabetes, are present.
Original languageEnglish
Pages (from-to)264-70
Number of pages7
JournalJournal of Human Hypertension
Volume21
Issue number4
DOIs
Publication statusPublished - 1 Apr 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Hypertension and fatty liver: guilty by association?'. Together they form a unique fingerprint.

Cite this